TARGETSCAPE
Live / Registered — Registered (as of 17 Mar 2020)
What this means for you
Registered since 17 Mar 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79271806
- Registration number
- 6010552
- Mark type
- Word mark
- Filed
- 14 Aug 2019
- Published for opposition
- 31 Dec 2019
- Registered
- 17 Mar 2020
Goods and services
- Class 001 — Chemicals: Laboratory reagents for scientific use; laboratory reagents for scientific use; reagents for laboratory purposes, other than for medical or veterinary purposes; reagents and reagents in kit form for scientific research use; diagnostic biochemical, chemical and biological reagents for laboratory or scientific purposes, other than for medical or veterinary use; reagents for use in biological analysis; reagents and reagents in kit form for immune profiling
- Class 042 — Scientific and technological services: Laboratory research services in the field of biotechnology; laboratory research services in the field of immune profiling; laboratory research services in the field of vaccines; laboratory research services in the field of immunotherapy; laboratory research services in the field of immunotherapy products; laboratory research services relating to vaccines for use in the field of immunotherapy; laboratory research services in the field of vaccines, namely, immunotherapies for the treatment of infectious diseases and cancer; laboratory research services, namely, probing for multiple t cell specificities for identification of tumor antigen-specific T cells for the treatment of cancer; laboratory research services, namely, probing for multiple T cell specificities for identification of viral antigen-specific T cells in the field of infectious diseases; laboratory research services, namely, phenotypic and functional t cell and/or other immune cells profiling for use in the field of immunotherapy; laboratory research services, namely, analysis by time-of-flight mass cytometry; laboratory research services, namely, analysis by flow cytometry; laboratory research services in the field of biomarker discovery; clinical research services for determining a response to treatment for patient stratification via biomarkers, namely, determining the presence of biomarkers in patient samples; laboratory research services, namely, characterization of biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers for the identification of patients and the treatment efficacy or prevention of diseases, disorders and conditions associated with the immune system
Owner
Prosecution history
- 15 May 2020 — NOTIFICATION PROCESSED BY IB
- 28 Apr 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 28 Apr 2020 — FINAL DISPOSITION PROCESSED
- 16 Apr 2020 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 17 Mar 2020 — REGISTERED-PRINCIPAL REGISTER
- 04 Jan 2020 — NOTIFICATION PROCESSED BY IB
- 31 Dec 2019 — PUBLISHED FOR OPPOSITION
- 18 Dec 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 18 Dec 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 11 Dec 2019 — NOTICE OF PUBLICATION
- 25 Nov 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Nov 2019 — APPLICATION FILING RECEIPT MAILED
- 18 Nov 2019 — ASSIGNED TO EXAMINER
- 18 Nov 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Nov 2019 — SN ASSIGNED FOR SECT 66A APPL FROM IB